MEASUREMENT OF HYDROGEN SULFIDE DURING BREATH TEST

DK3586131T3Active Publication Date: 2026-06-29CEDARS SINAI MEDICAL CENT
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
DK · DK
Patent Type
Patents
Current Assignee / Owner
CEDARS SINAI MEDICAL CENT
Filing Date
2018-02-23
Publication Date
2026-06-29

AI Technical Summary

Technical Problem

Current breath tests for small intestinal bacterial overgrowth (SIBO) do not include hydrogen sulfide (H2S) measurements, which are associated with specific clinical symptoms like diarrhea, fatigue, abdominal pain, and bowel urgency, limiting their diagnostic capabilities.

Method used

Incorporating hydrogen sulfide (H2S) measurement in breath tests to diagnose and treat H2S-positive conditions such as SIBO, diarrhea, fatigue, abdominal pain, and bowel urgency by administering treatments like rifaximin based on H2S levels in biological samples.

Benefits of technology

Enhances the diagnostic accuracy for H2S-related conditions and provides targeted treatment options, reducing symptom severity and improving patient outcomes.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.